The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2012-03-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.1121623109PMID 22451913PMCID PMC3340046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abstract 808: Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology

  2010cited by this paper
• Macrophages as mediators of tumor immunosurveillance.

  2010cited by this paper
• Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma.

  2010cited by this paper
• Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

  2010cited by this paper
• Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47

  2010cited by this paper
• Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

  2009cited by this paper
• CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis.

  2009cited by this paper
• CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

  2009cited by this paper
• Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells

  2008cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Analysis of Gene Expression in Early-Stage Ovarian Cancer

  2008cited by this paper
• The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.

  2008cited by this paper
• Macrophage polarization in tumour progression.

  2008cited by this paper
• Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome

  2008cited by this paper
• Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

  2007cited by this paper
• Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.

  2007cited by this paper
• Phenotypic characterization of human colorectal cancer stem cells

  2007cited by this paper
• Calreticulin exposure dictates the immunogenicity of cancer cell death

  2007cited by this paper
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data

  2005cited by this paper
• Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte.

  2005cited by this paper
• Gene Expression Profiling of Gliomas Strongly Predicts Survival

  2004cited by this paper
• Role of CD47 in Erythroid Cells and in Autoimmunity

  2004cited by this paper
• Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression.

  2004cited by this paper
• Tumour-educated macrophages promote tumour progression and metastasis

  2004cited by this paper
• Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.

  2003cited by this paper
• Alternative activation of macrophages

  2003cited by this paper
• On the exact distribution of maximally selected rank statistics

  2003cited by this paper
• Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization.

  2002cited by this paper
• C1q and Mannose Binding Lectin Engagement of Cell Surface Calreticulin and Cd91 Initiates Macropinocytosis and Uptake of Apoptotic Cells

  2001cited by this paper
• Phosphatidylserine (PS) induces PS receptor–mediated macropinocytosis and promotes clearance of apoptotic cells

  2001cited by this paper
• Integrin-associated protein (CD47) and its ligands.

  2001influential reference
• Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor–Mediated Phagocytosis

  2001cited by this paper
• Cd47 (Integrin-Associated Protein) Engagement of Dendritic Cell and Macrophage Counterreceptors Is Required to Prevent the Clearance of Donor Lymphohematopoietic Cells

  2001cited by this paper
• Role of CD47 as a marker of self on red blood cells.

  2000influential reference
• CD47, a Ligand for the Macrophage Fusion Receptor, Participates in Macrophage Multinucleation*

  2000cited by this paper
• Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets

  2000cited by this paper
• Integrin-associated Protein Is a Ligand for the P84 Neural Adhesion Molecule*

  1999cited by this paper
• The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells.

  1998cited by this paper
• The Thrombospondin Receptor CD47 (IAP) Modulates and Associates with α2β1 Integrin in Vascular Smooth Muscle Cells

  1998cited by this paper
• Identification of Major Binding Proteins and Substrates for the SH2-Containing Protein Tyrosine Phosphatase SHP-1 in Macrophages

  1998cited by this paper
• A family of proteins that inhibit signalling through tyrosine kinase receptors

  1997cited by this paper
• A novel membrane glycoprotein, SHPS-1, that binds the SH2-domain-containing protein tyrosine phosphatase SHP-2 in response to mitogens and cell adhesion

  1996cited by this paper
• Intratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer model.

  1995cited by this paper
• Isolation and characterization of CD47 glycoprotein: a multispanning membrane protein which is the same as integrin-associated protein (IAP) and the ovarian tumour marker OA3.

  1994cited by this paper
• Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding

  1993cited by this paper
• Expression of the 50-kDa integrin-associated protein on myeloid cells and erythrocytes.

  1992cited by this paper
• Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Bmc Medical Genomics Gene Expression Analysis of Glioblastomas Identifies the Major Molecular Basis for the Prognostic Benefit of Younger Age

  year unknowncited by this paper

• Fitness Training for γδ T cells in mouse and human atherosclerosis takes place in plaques and artery tertiary lymphoid organs

  2026cites this paper
• Screening and mechanistic investigation of key radioresistance genes in oral squamous cell carcinoma

  2026cites this paper
• Immune Checkpoint Inhibitor-Induced Cardiovascular Disease: The Role of Accelerated Senescence in Vascular Dysfunction

  2026cites this paper
• From Inflammation to Targeted Therapy: Leveraging Neutrophil, Platelet, RBC, and Macrophage Biology for Nanocarrier in Atherosclerosis

  2026cites this paper
• Hyperactivated YAP1 Drives an Invasive EMT Subtype of Cervical Squamous Cell Carcinoma

  2026cites this paper
• Pig Lung Xenotransplantation: Barriers on the Road to Clinical Translation

  2026cites this paper
• Modulation of Tumor Microenvironment via Antibody Mediated Precision Delivery of CpG to Myeloid Cell.

  2026cites this paper
• Disrupting the Immunosuppressive Myeloid Compartment in Solid Tumors

  2026cites this paper
• Opportunities and challenges of targeting cGAS–STING in cancer

  2026cites this paper
• Molecular heterogeneity of Glioblastoma-associated microglia and macrophages and myeloid-derived suppressor cells: Insights from single-cell omics and therapeutic implications.

  2026cites this paper
• CD47 destabilization via manipulating the SPOP-USP2 axis augments macrophage phagocytosis and cancer immunotherapy

  2026cites this paper
• Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers

  2026cites this paper
• Positron Emission Tomography of CD47/SIRPα Axis and Image-Informed Therapeutic Design

  2026cites this paper
• CD52 signaling via macrophage Siglec-G represents a therapeutic target for cancer immunotherapy

  2026cites this paper
• Therapeutic applications of cell membrane-coated nanoparticles in oral diseases: Opportunities, challenges, and future perspectives

  2026cites this paper
• The nexus of mechanical stress, integrin signaling, and endocytosis in osteoarthritis

  2026cites this paper
• Engineered Bacteria Factory Integrating Drug Delivery and Antibody Manufacture for Activating the STING Signal Pathway Mediated Tumor Immunotherapy.

  2026cites this paper
• Clinical advances in CD47-SIRPα axis-targeted cancer immunotherapy: Mechanisms, strategies, challenges, and future perspectives.

  2026cites this paper
• CD47 blockade-driven necroptosis complements BCL-2 inhibition-driven apoptosis in lymphoid malignancies

  2026cites this paper
• Reprogramming Macrophage via an Antigen Phagocytosis-Presentation Nanoenhancer for Improved Cancer Immunotherapy.

  2025cites this paper
• Functional Differences Between SIRPα Splice Isoforms

  2025cites this paper
• CD47 blockade enhances cisplatin sensitivity by inhibiting DNA repair gene expression.

  2025cites this paper
• New nonchemotherapy treatment options for cutaneous T-cell lymphomas an update

  2025influential citation
• The value of CD47 and CAP1 levels in early diagnosis and MACE prediction for patients with non-ST-segment elevation myocardial infarction

  2025cites this paper
• Therapeutic landscape of primary refractory and relapsed diffuse large B-cell lymphoma: Recent advances and emerging therapies

  2025cites this paper
• Molecular comparison reveals distinct transcriptomic differences between uterine carcinosarcoma and papillary serous carcinoma distinguishable by DNA damage.

  2025cites this paper
• Translational contrast agents for use in fluorescence image-guided tumor surgery.

  2025cites this paper
• Identification and validation of cell phagocytosis-related genes for prognosis in breast cancer: A study of diagnostic relevance in breast cancer

  2025cites this paper
• Human Single-Nucleus RNA Sequencing Identifies CD47 as a Therapeutic Target for Doxorubicin-Induced Cardiomyopathy.

  2025cites this paper
• Model‐Informed Optimal Dosing of Anti‐CD47 Antibody Using Target‐Mediated Drug Disposition Model

  2025cites this paper
• Interrogation of macrophage-related prognostic signatures reveals a potential immune-mediated therapy strategy by histone deacetylase inhibition in glioma

  2025cites this paper
• Engineering Efferocytosis for Bone Regeneration

  2025cites this paper
• Focused Acoustic Vortex-Activated Dual-Stimuli Nanoplatform Synergizes with Checkpoint Blockade to Enhance Macrophage Phagocytosis and Antitumor Immunity.

  2025cites this paper
• Refining the Role of Tumor-Associated Macrophages in Oral Squamous Cell Carcinoma

  2025cites this paper
• Targeted CD47 checkpoint blockade using a mesothelin-directed antibody construct for enhanced solid tumor-specific immunotherapy

  2025cites this paper
• Immunotherapy of endometrial cancer via CD47 blockade-mediated macrophage phagocytosis

  2025influential citation
• Insights Into Heart-Tumor Interactions in Heart Failure

  2025cites this paper
• MSigSeg: An R package for multiple signals segmentation

  2025cites this paper
• Oncogene SETDB1’s Dual Role in Endometrial Cancer: Driving Tumor Progression and Immune Escape

  2025cites this paper
• A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors

  2025cites this paper
• Extracellular vesicles in cancer´s communication: messages we can read and how to answer

  2025cites this paper
• Phagocytosis‐Activating Nanocomplex Orchestrates Macrophage‐Mediated Cancer Immunotherapy

  2025cites this paper
• Comparison of accumulation and distribution of PEGylated and CD-47-functionalized magnetic nanoporous silica nanoparticles in an in vivo mouse model of implant infection

  2025cites this paper
• Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway

  2025cites this paper
• Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers

  2025cites this paper
• Chronic compression drives macrophages toward a pathological pro-tumor state

  2025cites this paper
• Immunotherapeutic Blockade of CD47 Increases Virus Neutralization Antibodies

  2025cites this paper
• Emerging Immunotherapy Targets in Early Drug Development

  2025cites this paper
• Unleashing the power of CAR-M therapy in solid tumors: a comprehensive review

  2025cites this paper
• SIRPα blockade therapy potentiates immunotherapy by inhibiting PD-L1+ myeloid cells in hepatocellular carcinoma

  2025cites this paper
• Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics

  2025cites this paper
• Post-translational modifications of cancer immune checkpoints: mechanisms and therapeutic strategies

  2025cites this paper
• Expression of Signal Regulatory Protein Alpha in Tumor Cells is the Key Factor in Intrahepatic Cholangiocarcinoma

  2025cites this paper
• Localized Delivery of the mRNAs Encoding CD47 Inhibitor and Interleukins 12, 15, and 21 Elicits Robust Antitumor Immunity

  2025cites this paper
• In vivo generation of CAR macrophages via the enucleated mesenchymal stem cell delivery system for glioblastoma therapy

  2025cites this paper
• Enhancing macrophage phagocytosis of cancers by disrupting the SIRPα/CD47 signaling axis and targeting MUC1 antigen

  2025cites this paper
• Single-cell and spatial transcriptomics reveal mechanisms of radioresistance and immune escape in recurrent nasopharyngeal carcinoma

  2025cites this paper
• Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches

  2025cites this paper
• Mathematical model of tumor-macrophage dynamics in glioma to advance myeloid-targeted therapies

  2025influential citation
• Reprogramming of Myeloid Responses to Volumetric Muscle Loss via Engineered Protein Nanoparticles.

  2025cites this paper
• A Novel Prognostic Model of Endometrial Cancer Based on Inflammation and Lipid Metabolism Genes

  2025cites this paper
• The distinct landscape of tumor immune microenvironment in homologous recombination deficient cancers

  2025influential citation
• High-Throughput Screening on Primary Tumor-Associated Microglia and Macrophages Identifies HDAC Inhibitors as Enhancers of Phagocytosis and Potent Partners for Immunotherapy in Glioblastoma

  2025cites this paper
• TAMing Gliomas: Unraveling the Roles of Iba1 and CD163 in Glioblastoma

  2025cites this paper
• The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications

  2025cites this paper
• Ezrin works as a scaffold protein for a macrophage checkpoint molecule CD47, leading to a poor prognosis for patients with uterine cervical squamous cell carcinoma.

  2025cites this paper
• Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment.

  2025cites this paper
• NIR-activated endoplasmic reticulum stress amplifier to regulate phagocytosis for macrophage-mediated cancer immunotherapy

  2025cites this paper
• CD47 prevents Rac-mediated phagocytosis through Vav1 dephosphorylation

  2025cites this paper
• Augmenting Antitumor Immune Effects through the Coactivation of cGAS-STING and NF-κB Crosstalk in Dendritic Cells and Macrophages by Engineered Manganese Ferrite Nanohybrids.

  2025cites this paper
• CD47-blocking antibody interferes with neutrophil extracellular traps formation after spinal cord injury to reduce spinal cord edema.

  2025cites this paper
• Editorial: Deciphering the regulatory role of transcription factors in cancer immune infiltration

  2025cites this paper
• Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects

  2025cites this paper
• Implication of TRPM8, CD47, and CDK4 expressions in hepatocellular carcinoma progression

  2025cites this paper
• SLAMF8 regulates Fc receptor-mediated phagocytosis in mouse macrophage cells through PI3K-Akt signaling.

  2025cites this paper
• GW501516 facilitated tumor immune escape by inhibiting phagocytosis.

  2025cites this paper
• Interferon-driven Metabolic Reprogramming and Tumor Microenvironment Remodeling

  2025cites this paper
• Whole genome insights into genetic diversity, introgression, and adaptation of Yunnan indigenous cattle of Southwestern China

  2025cites this paper
• Tumor-infiltrating and circulating B cells mediate local and systemic immunomodulatory mechanisms in Glioblastoma

  2025cites this paper
• Submicron-sized superantigen biomimetic liposomes with highly efficient pulmonary accumulation to remodel local immune microenvironment for cancer chemoimmunotherapy

  2025cites this paper
• Multispecific Antibodies Targeting PD-1/PD-L1 in Cancer

  2025cites this paper
• The Role of Diet and the Gut Microbiota in the Obesity-Colorectal Cancer Link

  2025cites this paper
• Research Progress of CD47-SIRPα in Esophageal Cancer

  2025cites this paper
• Generation and characterization of 7DC-DM1: a non-cleavable CD47-targeting antibody-drug conjugates with antitumor effects.

  2025cites this paper
• Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study

  2025cites this paper
• The Efficacy of Targeted Monoclonal IgA Antibodies Against Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• Dual-mode action of scalable, high-quality engineered stem cell-derived SIRPα-extracellular vesicles for treating acute liver failure

  2025cites this paper
• CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation

  2025cites this paper
• Nanobody-Based PET Imaging of CD47 Expression in Thyroid Carcinoma.

  2025cites this paper
• Refolding of the Recombinant IgV domain of CD47 from E. coli for NMR Studies.

  2025cites this paper
• Engineered Bacterial Biohybrid-Mediated CD47-SIRPα Blockade and HSP90 Inhibition for Enhanced Immuno-Photothermal Therapy.

  2025cites this paper
• Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCT.

  2025cites this paper
• Targeting Siglec-10/α3β1 Integrin Interactions Enhances Macrophage-Mediated Phagocytosis of Pancreatic Cancer

  2025cites this paper
• USP2 inhibition unleashes CD47-restrained phagocytosis and enhances anti-tumor immunity

  2025cites this paper
• Graphene Oxide‐Based Gene Modulation in Preferential Elimination of Lung Cancer Cells in a 3D Tumor Microenvironment Model

  2025cites this paper
• Novel immunotherapy for gastric cancer: targeting the CD47–SIRPα axis

  2025influential citation
• Liver macrophages: development, dynamics, and functions

  2025cites this paper
• STAT3 inhibition in combination with CD47 blockade inhibits osteosarcoma lung metastasis

  2025cites this paper
• A novel molecule targeting neutrophil-mediated B-1a cell trogocytosis attenuates sepsis-induced acute lung injury

  2025cites this paper
• CV1-secreting sCAR-T cells potentiate the abscopal effect of microwave ablation in heterogeneous tumors

  2025cites this paper